Oncology Nurse In Charge BWH
Brigham and Women's Hospital | |
United States, Massachusetts, Boston | |
75 Francis Street (Show on map) | |
Nov 11, 2025 | |
|
Nurse in Charge / 36 Hours Variable Rotating / Oncology 4A
The Nurse in Charge (NIC) is a designated clinical leader for a given patient care area who works collaboratively with the Nursing Director (ND)and Assistant Nurse Director (AND) in planning and implementing patient care at the service/department level. The nurse in charge is accountable for cost-effective decision making regarding daily assignment of staff, use of supplies, and day-to-day operational decision making. The NIC participates in the clinical patient care standard development, evaluation of outcomes, and development of improvement initiatives. The NIC participates in the assessment of staff performance through contributions to individual staff performance reviews. The NIC is accountable for identifying competency issues and participating in the development and implementation of the plan for performance improvement. The NIC reports to the Nursing Director. Education: - For external applicants: Bachelor's or master's in nursing required. Can this role accept experience in lieu of a degree? - Experience in medical oncology required - Membership in professional organizations is recommended and certification in specialty areas is encouraged. The Brigham and Women's Hospital, Inc. is an Equal Opportunity Employer. By embracing diverse skills, perspectives and ideas, we choose to lead. All qualified applicants will receive consideration for employment without regard to race, color, religious creed, national origin, sex, age, gender identity, disability, sexual orientation, military service, genetic information, and/or other status protected under law. We will ensure that all individuals with a disability are provided a reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. | |
Nov 11, 2025